• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体在视网膜中央静脉阻塞中的作用。

Role of the vitreous in central retinal vein occlusion.

作者信息

Hikichi T, Konno S, Trempe C L

机构信息

Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

出版信息

Retina. 1995;15(1):29-33. doi: 10.1097/00006982-199515010-00006.

DOI:10.1097/00006982-199515010-00006
PMID:7754244
Abstract

PURPOSE

The role of the vitreous in eyes with CRVO and its relationship to neovascularization and macular edema, in particular, were investigated.

METHODS

A retrospective chart review of the vitreous condition of 136 patients (136 eyes) with CRVO was performed. Based on fluorescein angiography findings and color photographs, eyes with CRVO were classified as either ischemic or nonischemic.

RESULTS

In ischemic cases, retinal or optic disc neovascularization or both developed in 8 (57%) of 14 eyes with no or partial posterior vitreous detachment (PVD) at the final examination. The prevalence of neovascularization was significantly higher than in eyes with complete PVD (0%, 0 of 38) at the final examination (P < 0.01). No significant relationship was found between iris neovascularization development and the vitreous condition or between the prevalence of PVD and macular edema. In nonischemic eyes, the prevalence of no PVD or partial PVD with vitreomacular attachment was significantly higher in those with macular edema (76%, 25 of 33) than in eyes without (25%, 13 of 51) at the final examination (P < 0.01).

CONCLUSION

Complete PVD may protect against retinal or optic disc neovascularization in eyes with severe CRVO. Vitreomacular attachment may cause persistent macular edema in eyes with mild CRVO.

摘要

目的

研究玻璃体在视网膜中央静脉阻塞(CRVO)眼中的作用及其与新生血管形成和黄斑水肿的关系,尤其是二者之间的关系。

方法

对136例(136只眼)CRVO患者的玻璃体状况进行回顾性病历分析。根据荧光素血管造影结果和彩色照片,将CRVO眼分为缺血性或非缺血性。

结果

在缺血性病例中,在最后检查时,14只无或部分玻璃体后脱离(PVD)的眼中有8只(57%)出现视网膜或视盘新生血管形成或两者皆有。最后检查时,新生血管形成的发生率显著高于完全PVD的眼(0%,38只眼中0只)(P<0.01)。未发现虹膜新生血管形成与玻璃体状况之间或PVD发生率与黄斑水肿之间存在显著关系。在非缺血性眼中,最后检查时,黄斑水肿患者中无PVD或伴有玻璃体黄斑粘连的部分PVD的发生率(76%,33只眼中25只)显著高于无黄斑水肿的眼(25%,51只眼中13只)(P<0.01)。

结论

完全PVD可能预防严重CRVO眼中视网膜或视盘新生血管形成。玻璃体黄斑粘连可能导致轻度CRVO眼中持续性黄斑水肿。

相似文献

1
Role of the vitreous in central retinal vein occlusion.玻璃体在视网膜中央静脉阻塞中的作用。
Retina. 1995;15(1):29-33. doi: 10.1097/00006982-199515010-00006.
2
[Role of the vitreous in central retinal vein occlusion].[玻璃体在视网膜中央静脉阻塞中的作用]
Nippon Ganka Gakkai Zasshi. 1996 Jan;100(1):63-8.
3
[Role of the vitreous in retinal neovascularization evaluated by a comparison of central retinal vein occlusion and branch retinal vein occlusion].[通过比较视网膜中央静脉阻塞和视网膜分支静脉阻塞评估玻璃体在视网膜新生血管形成中的作用]
Nippon Ganka Gakkai Zasshi. 1989 Aug;93(8):812-6.
4
Vitreous changes and macular edema in central retinal vein occlusion.视网膜中央静脉阻塞中的玻璃体变化和黄斑水肿。
Ophthalmic Surg. 1990 Aug;21(8):544-9.
5
Role of the vitreous in posterior segment neovascularization in central retinal vein occlusion.玻璃体在视网膜中央静脉阻塞后段新生血管形成中的作用。
Ophthalmic Surg. 1991 Sep;22(9):498-502.
6
The impact of posterior vitreous adhesion on ischaemia in eyes with retinal vein occlusion.玻璃体后粘连对视网膜静脉阻塞患者眼部缺血的影响。
Acta Ophthalmol. 2016 Feb;94(1):e43-8. doi: 10.1111/aos.12815. Epub 2015 Aug 20.
7
Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion.玻璃体内注射组织型纤溶酶原激活剂诱导的玻璃体后脱离在视网膜中央静脉阻塞性黄斑水肿中的作用
Retina. 2007 Oct;27(8):1031-7. doi: 10.1097/IAE.0b013e318074bc39.
8
Role of the vitreous and macular edema in branch retinal vein occlusion.玻璃体及黄斑水肿在视网膜分支静脉阻塞中的作用。
Ophthalmic Surg Lasers. 1997 Apr;28(4):294-9.
9
Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.视网膜中央静脉阻塞所致黄斑水肿中白细胞介素-6和血管内皮生长因子的玻璃体液水平
Ophthalmology. 2009 Jan;116(1):87-93. doi: 10.1016/j.ophtha.2008.09.034.
10
SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.玻璃体内注射Ozurdex®治疗视网膜静脉阻塞合并黄斑囊样水肿的频域光学相干断层扫描图像特征
Eur J Ophthalmol. 2011 Sep-Oct;21(5):631-6. doi: 10.5301/EJO.2011.7428.

引用本文的文献

1
Posterior Vitreous Detachment and Risk of Neovascular Glaucoma in Eyes with Prior Retinal Vascular Occlusions.既往有视网膜血管阻塞的眼睛中玻璃体后脱离与新生血管性青光眼的风险
Ophthalmol Ther. 2024 Nov;13(11):3013-3024. doi: 10.1007/s40123-024-01039-1. Epub 2024 Sep 29.
2
Multimodal Imaging of Microvascular Abnormalities in Retinal Vein Occlusion.视网膜静脉阻塞微血管异常的多模态成像
J Clin Med. 2021 Jan 21;10(3):405. doi: 10.3390/jcm10030405.
3
Glycosaminoglycans from bovine eye vitreous humour and interaction with collagen type II.牛眼玻璃体中的糖胺聚糖及其与 II 型胶原的相互作用。
Glycoconj J. 2018 Feb;35(1):119-128. doi: 10.1007/s10719-017-9808-1. Epub 2018 Jan 5.
4
Neovascularization of the iris in retinoschisis.
Am J Ophthalmol Case Rep. 2017 Jun 22;7:99-101. doi: 10.1016/j.ajoc.2017.06.019. eCollection 2017 Sep.
5
A pharmacological approach in newly established retinal vein occlusion model.一种新建立的视网膜静脉阻塞模型的药理学方法。
Sci Rep. 2017 Mar 2;7:43509. doi: 10.1038/srep43509.
6
Strategy for the management of macular edema in retinal vein occlusion: the European VitreoRetinal Society macular edema study.视网膜静脉阻塞性黄斑水肿的管理策略:欧洲玻璃体视网膜学会黄斑水肿研究
Biomed Res Int. 2015;2015:870987. doi: 10.1155/2015/870987. Epub 2015 Jan 29.
7
Lens subluxation after plasmin and SF6 injections in rabbit eyes.兔眼注射纤溶酶和六氟化硫后晶状体半脱位
PLoS One. 2014 Nov 14;9(11):e112957. doi: 10.1371/journal.pone.0112957. eCollection 2014.
8
[Intravitreal fibrinolysis and retinal vein occlusion].[玻璃体内纤维蛋白溶解与视网膜静脉阻塞]
Ophthalmologe. 2015 Feb;112(2):155-61. doi: 10.1007/s00347-014-3107-z.
9
[Vitreous body and retinal vein occlusion].[玻璃体与视网膜静脉阻塞]
Ophthalmologe. 2014 Dec;111(12):1178-82. doi: 10.1007/s00347-014-3086-0.
10
Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion.奥克纤溶酶简介及其在治疗玻璃体黄斑黏附中的潜力。
Clin Ophthalmol. 2014 May 6;8:847-56. doi: 10.2147/OPTH.S32274. eCollection 2014.